← Open Payments lookup

KIMBERLY SCHMID: Open Payments

NPI 1619990918 · EMPORIA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$452 in 23 payments from 11 companies in 2025. Trend: 2023 $199 · 2024 $307 · 2025 $452

Food & beverage: $452
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$176
PFIZER INC.3$61
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$44
Lundbeck LLC2$37
Amgen Inc.2$30
Novo Nordisk Inc1$20
Merck Sharp & Dohme LLC1$20
Lilly USA, LLC1$19
Boehringer Ingelheim Pharmaceuticals, Inc.1$15
Biogen, Inc.1$15

Products named: AIRSUPRA, FARXIGA, PREVNAR 20, CAPLYTA, REXULTI, ROTATEQ, MOUNJARO, EVENITY.

Industry payments across KS — which companies pay providers there.